sebi

US FDA TO HOLD MAY 12 PUBLIC MEETING OVER NICOX'S <NCOX.PA> NONSTEROIDAL ANTI-INFLAMMATORY DRUG NAPROXCINOD

14:50 05Mar10 RTRS-US FDA TO HOLD MAY 12 PUBLIC MEETING OVER NICOX'S <NCOX.PA> NONSTEROIDAL ANTI-INFLAMMATORY DRUG NAPROXCINOD

14:58 05Mar10 RTRS-BRIEF-NicOx faces May 12 FDA meeting for naproxcinod NSAID

WASHINGTON, March 5 (Reuters) - The U.S. Food and Drug Administration on Friday said: * The agency will hold a May 12 public meeting over NicOx SA's <NCOX.PA>

nonsteroidal anti-inflammatory drug (NSAID) called naproxcinod to treat

osteoarthritis * The FDA posted the announcement on its website at

http://www.federalregister.gov/OFRUpload/OFRData/2010-04813_PI.pdf

((Company news desk in Washington; +1 202 898 8400, washington.newsroom@thomsonreuters.com))



For Related News, Double Click on one of these codes:[E] [U] [RNP] [PCO] [PCU] [US] [GEN] [PIL] [POL] [WASH] [BACT] [REGS] [HEA] [NSS] [DRU] [BIOT] [HECA] [MRCH] [PHMR] [PHAG] [PHAR] [PHAD] [EUROPE] [EZC] [FR] [WEU] [LEN] [RTRS] [NCOX.PA]

For Relevant Price Information, Double Click on one of these codes:<NCOX.PA>

Friday, 05 March 2010 14:50:43RTRS [nWEN1325] {EN}ENDS